204 related articles for article (PubMed ID: 35945009)
21. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
Petruzzi M; Galleggiante S; Messina S; Della Vella F
BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
[TBL] [Abstract][Full Text] [Related]
22. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
23. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
24. COVID Vaccine-Associated Uveitis.
Habot-Wilner Z; Neri P; Okada AA; Agrawal R; Xin Le N; Cohen S; Fischer N; Kilmartin F; Coman A; Kilmartin D
Ocul Immunol Inflamm; 2023 Aug; 31(6):1198-1205. PubMed ID: 37145198
[TBL] [Abstract][Full Text] [Related]
25. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
26. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K
Front Immunol; 2021; 12():704773. PubMed ID: 34220867
[TBL] [Abstract][Full Text] [Related]
27. A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.
Park S; You J
J Korean Med Sci; 2022 Apr; 37(16):e131. PubMed ID: 35470603
[TBL] [Abstract][Full Text] [Related]
28. Myocarditis following mRNA COVID-19 vaccination: call for endomyocardial biopsy.
Kiblboeck D; Klingel K; Genger M; Traxler S; Braunsteiner N; Steinwender C; Kellermair J
ESC Heart Fail; 2022 Jun; 9(3):1996-2002. PubMed ID: 35194974
[TBL] [Abstract][Full Text] [Related]
29. Association of Systemic Adverse Reactions and Serum SARS-CoV-2 Spike Protein Antibody Levels after Administration of BNT162b2 mRNA COVID-19 Vaccine.
Takahashi W; Mizuno T; Hara K; Ara Y; Hurutani R; Agatsuma T; Fujimori M
Intern Med; 2022 Nov; 61(21):3205-3210. PubMed ID: 35989281
[TBL] [Abstract][Full Text] [Related]
30. Relapsing Anti-MOG Antibody-associated Disease following COVID-19 Vaccination: A Rare Case Report and Review of the Literature.
Nakano H; Yamaguchi K; Hama N; Matsumoto Y; Shinohara M; Ide H
Intern Med; 2023 Mar; 62(6):923-928. PubMed ID: 36575011
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
Kobashi Y; Shimazu Y; Kawamura T; Nishikawa Y; Omata F; Kaneko Y; Kodama T; Tsubokura M
PLoS One; 2022; 17(6):e0269917. PubMed ID: 35687563
[TBL] [Abstract][Full Text] [Related]
32. Eyelid edema following the first Pfizer-BioNTech COVID-19 vaccination: is it a coincidence?
Baysal Z; Gobeka HH
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5264-5267. PubMed ID: 35916826
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
[TBL] [Abstract][Full Text] [Related]
34. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
[TBL] [Abstract][Full Text] [Related]
35. Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
Montoya JG; Adams AE; Bonetti V; Deng S; Link NA; Pertsch S; Olson K; Li M; Dillon EC; Frosch DL
Microbiol Spectr; 2021 Dec; 9(3):e0116221. PubMed ID: 34756093
[TBL] [Abstract][Full Text] [Related]
36. Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing.
Siripipattanamongkol N; Rattanasak S; Taiyaitieng C; Inthajak Y; Kuawatcharawong N; Sukasem C; Tempark T
Pediatr Dermatol; 2022 Jul; 39(4):601-605. PubMed ID: 36000937
[TBL] [Abstract][Full Text] [Related]
37. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
Consoli S; Dono F; Evangelista G; D'Apolito M; Travaglini D; Onofrj M; Bonanni L
Neurol Sci; 2022 Feb; 43(2):767-770. PubMed ID: 34807361
[TBL] [Abstract][Full Text] [Related]
38. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
[No Abstract] [Full Text] [Related]
39. Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
Syenina A; Gan ES; Toh JZN; de Alwis R; Lin LZ; Tham CYL; Yee JX; Leong YS; Sam H; Cheong C; Teh YE; Wee ILE; Ng DHL; Chan KR; Sim JXY; Kalimuddin S; Ong EZ; Low JG; Ooi EE
PLoS Biol; 2022 May; 20(5):e3001643. PubMed ID: 35639676
[TBL] [Abstract][Full Text] [Related]
40. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
Abi Zeid Daou C; Natout MA; El Hadi N
J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
